Background: Self-management is considered important in the management of patients with idiopathic pulmonary fibrosis (IPF) or sarcoidosis. However, data about the degree of activation for self-management is lacking. Objectives: The aim of the study was to determine the degree of activation for self-management in patients with IPF or sarcoidosis using the Patient Activation Measure (PAM) and to evaluate the association between PAM scores, clinical characteristics, and health-related outcomes. Study Design and Methods: This cross-sectional prospective study assessed besides the PAM also demographics, lung function, dyspnea (modified Medical Research Council [mMRC]), fatigue (Checklist Individual Strength-Fatigue [CIS-Fatigue]), anxiety/depression (Hospital Anxiety and Depression Scale [HADS-A/HADS-D]), and generic health status (EuroQol five-dimensional-five-level [EQ-5D-5L]). Results: Mean PAM was 55.0 (9.1) points in patients with IPF (n = 59) and low levels of patient activation for self-management (PAM ≤55.1 points) were present in 56% of the patients. PAM Scores correlated significantly (p < 0.05) with mMRC (ρ = −0.476), HADS-A (ρ = −0.326), HADS-D (ρ = −0.459), and EQ-5D-5L (ρ = 0.393). In patients with sarcoidosis (n = 59), the mean PAM score was 55.7 (11.0) points, and 46% of the patients reported low PAM levels. Significant correlations were found with mMRC (ρ = -0.356), HADS-A (ρ = −0.394), HADS-D (ρ = −0.478), and EQ-5D-5L (ρ = 0.313). Conclusion: About half of the outpatients with IPF or sarcoidosis have a low degree of activation for self-management, and these patients generally report more dyspnea, anxiety, depression, and a lower health status. Whether patients with a low degree of activation can be successful in self-managing their disease remains to be determined.

1.
Bradley
B
,
Branley
HM
,
Egan
JJ
,
Greaves
MS
,
Hansell
DM
,
Harrison
NK
,
British thoracic society interstitial lung disease guideline group, british thoracic society standards of care committee, thoracic society of Australia, New Zealand thoracic society, Irish thoracic society. Interstitial lung disease guideline: the British thoracic society in collaboration with the thoracic society of Australia and New Zealand and the Irish thoracic society
.
Thorax
.
2008
;
63
(
Suppl 5
):
v1
58
.
2.
Travis
WD
,
Costabel
U
,
Hansell
DM
,
King
TE
 Jr
,
Lynch
DA
,
Nicholson
AG
,
An official American thoracic society/European respiratory society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias
.
Am J Respir Crit Care Med
.
2013
;
188
(
6
):
733
48
. .
3.
Hibbard
JH
,
Stockard
J
,
Mahoney
ER
,
Tusler
M
.
Development of the patient activation measure (PAM): conceptualizing and measuring activation in patients and consumers
.
Health Serv Res
.
2004
;
39
(
4p1
):
1005
26
. .
4.
Barlow
J
,
Wright
C
,
Sheasby
J
,
Turner
A
,
Hainsworth
J
.
Self-management approaches for people with chronic conditions: a review
.
Patient Educ Couns
.
2002
;
48
(
2
):
177
87
. .
5.
Lorig
KR
,
Holman
H
.
Self-management education: history, definition, outcomes, and mechanisms
.
Ann Behav Med
.
2003
;
26
(
1
):
1
7
. .
6.
Trappenburg
J
,
Jonkman
N
,
Jaarsma
T
,
van Os-Medendorp
H
,
Kort
H
,
de Wit
N
,
Self-management: one size does not fit all
.
Patient Educ Couns
.
2013
;
92
(
1
):
134
7
. .
7.
Hibbard
JH
,
Greene
J
.
What the evidence shows about patient activation: better health outcomes and care experiences; fewer data on costs
.
Health Aff
.
2013
;
32
(
2
):
207
14
. .
8.
Greene
J
,
Hibbard
JH
,
Sacks
R
,
Overton
V
,
Parrotta
CD
.
When patient activation levels change, health outcomes and costs change, too
.
Health Aff
.
2015
;
34
(
3
):
431
7
. .
9.
Barker
I
,
Steventon
A
,
Williamson
R
,
Deeny
SR
.
Self-management capability in patients with long-term conditions is associated with reduced healthcare utilisation across a whole health economy: cross-sectional analysis of electronic health records
.
BMJ Qual Saf
.
2018
;
27
(
12
):
989
99
. .
10.
Hibbard
JH
,
Cunningham
PJ
.
How engaged are consumers in their health and health care, and why does it matter?
Washington, DC
:
Center for Studying Health System Change
;
2008
.
11.
Hibbard
J
,
Gilburt
H
.
Supporting people to manage their health. An introduction to patient activation
.
London
:
The King’s Fund
;
2014
.
12.
Hibbard
JH
,
Greene
J
,
Sacks
R
,
Overton
V
,
Parrotta
CD
.
Adding a measure of patient self-management capability to risk assessment can improve prediction of high costs
.
Health Aff
.
2016
;
35
(
3
):
489
94
. .
13.
Greene
J
,
Hibbard
JH
,
Sacks
R
,
Overton
V
.
When seeing the same physician, highly activated patients have better care experiences than less activated patients
.
Health Aff
.
2013
;
32
(
7
):
1299
305
. .
14.
Smith
SG
,
Pandit
A
,
Rush
SR
,
Wolf
MS
,
Simon
C
.
The association between patient activation and accessing online health information: results from a national survey of US adults
.
Health Expect
.
2015
;
18
(
6
):
3262
73
. .
15.
Moor
CC
,
Mostard
RL
,
Grutters
JC
,
Bresser
P
,
Aerts
JG
,
Chavannes
NH
,
Home monitoring in patients with idiopathic pulmonary fibrosis: a randomized controlled trial
.
Am J Crit Care Med
.
2020
;
202
(
3
):
393
401
.
16.
Eikelenboom
N
,
van Lieshout
J
,
Jacobs
A
,
Verhulst
F
,
Lacroix
J
,
van Halteren
A
,
Effectiveness of personalised support for self-management in primary care: a cluster randomised controlled trial
.
Br J Gen Pract
.
2016
;
66
(
646
):
e354
61
. .
17.
Raghu
G
,
Collard
HR
,
Egan
JJ
,
Martinez
FJ
,
Behr
J
,
Brown
KK
,
ATS/ERS/JRS/ALAT committee on idiopathic pulmonary fibrosis. an official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management
.
Am J Respir Crit Care Med
.
2011
;
183
(
6
):
788
824
.
18.
Hunninghake
GW
,
Costabel
U
,
Ando
M
,
Baughman
R
,
Cordier
JF
,
du Bois
R
,
ATS/ERS/WASOG statement on sarcoidosis. American thoracic dsociety/European respiratory society/world association of sarcoidosis and other granulomatous disorders
.
Sarcoidosis Vasc Diffuse Lung Dis
.
1999
;
16
(
2
):
149
73
.
19.
Zhou
Y
,
Lower
EE
,
Li
H
,
Baughman
RP
.
Clinical management of pulmonary sarcoidosis
.
Expert Rev Respir Med
.
2016
;
10
(
5
):
577
91
. .
20.
Rademakers
J
,
Nijman
J
,
van der Hoek
L
,
Heijmans
M
,
Rijken
M
.
Measuring patient activation in The Netherlands: translation and validation of the American short form patient activation measure (PAM13)
.
BMC Public Health
.
2012
;
12
(
1
):
577
. .
21.
Hibbard
JH
,
Mahoney
ER
,
Stockard
J
,
Tusler
M
.
Development and testing of a short form of the patient activation measure
.
Health Serv Res
.
2005
;
40
(
6
):
1918
30
. .
22.
Skolasky
RL
,
Green
AF
,
Scharfstein
D
,
Boult
C
,
Reider
L
,
Wegener
ST
.
Psychometric properties of the patient activation measure among multimorbid older adults
.
Health Serv Res
.
2011
;
46
(
2
):
457
78
. .
23.
Stepleman
L
,
Rutter
MC
,
Hibbard
J
,
Johns
L
,
Wright
D
,
Hughes
M
.
Validation of the patient activation measure in a multiple sclerosis clinic sample and implications for care
.
Disabil Rehabil
.
2010
;
32
(
19
):
1558
67
. .
24.
Insignia Health
.
The patient activation measure
;
2020
. Available from. https://www.insigniahealth.com.
25.
Quanjer
PH
,
Tammeling
GJ
,
Cotes
JE
,
Pedersen
OF
,
Peslin
R
,
Yernault
JC
.
Lung volumes and forced ventilatory flows. Work group on standardization of respiratory function tests. European community for coal and steelofficial position of the European respiratory society
.
Rev Mal Respir
.
1994
;
11
(
Suppl 3
):
5
40
.
26.
Bestall
JC
,
Paul
EA
,
Garrod
R
,
Garnham
R
,
Jones
PW
,
Wedzicha
JA
.
Usefulness of the medical research council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease
.
Thorax
.
1999
;
54
(
7
):
581
6
. .
27.
Nishiyama
O
,
Taniguchi
H
,
Kondoh
Y
,
Kimura
T
,
Kato
K
,
Kataoka
K
,
A simple assessment of dyspnoea as a prognostic indicator in idiopathic pulmonary fibrosis
.
Eur Respir J
.
2010
;
36
(
5
):
1067
72
. .
28.
Vercoulen
JH
,
Swanink
CM
,
Fennis
JF
,
Galama
JM
,
van der Meer
JW
,
Bleijenberg
G
.
Dimensional assessment of chronic fatigue syndrome
.
J Psychosom Res
.
1994
;
38
(
5
):
383
92
. .
29.
Worm-Smeitink
M
,
Gielissen
M
,
Bloot
L
,
van Laarhoven
HWM
,
van Engelen
BGM
,
van Riel
P
,
The assessment of fatigue: psychometric qualities and norms for the checklist individual strength
.
J Psychosom Res
.
2017
;
98
:
40
6
. .
30.
Zigmond
AS
,
Snaith
RP
.
The hospital anxiety and depression scale
.
Acta Psychiatr Scand
.
1983
;
67
(
6
):
361
70
. .
31.
Herdman
M
,
Gudex
C
,
Lloyd
A
,
Janssen
M
,
Kind
P
,
Parkin
D
,
Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)
.
Qual Life Res
.
2011
;
20
(
10
):
1727
36
. .
32.
Janssen
MF
,
Pickard
AS
,
Golicki
D
,
Gudex
C
,
Niewada
M
,
Scalone
L
,
Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study
.
Qual Life Res
.
2013
;
22
(
7
):
1717
27
. .
33.
van Reenen
M
,
Janssen
B
.
EQ-5D-5L user guide: basic information on how to use the EQ-5D-5L instrument
.
Rotterdam
:
EuroQol Research Foundation
;
2015
.
34.
Altman
DG
.
Practical statistics for medical research
.
CRC press
;
1990
.
35.
Cohen
J
.
Statistical power analysis for the behavioral sciences
.
Abingdon
;
1988
.
36.
Beurskens
S
.
Meten in de praktijk
.
Bohn Stafleu van Loghum
;
2008
.
37.
Akinwande
MO
,
Dikko
HG
,
Samson
A
.
Variance inflation factor: as a condition for the inclusion of suppressor variable (s) in regression analysis
.
Open J Stat
.
2015
;
5
(
07
):
754
.
38.
Overbeek
A
,
Rietjens
JAC
,
Jabbarian
LJ
,
Severijnen
J
,
Swart
SJ
,
van der Heide
A
,
Low patient activation levels in frail older adults: a cross-sectional study
.
BMC Geriatr
.
2018
;
18
(
1
):
7
0696
. .79
39.
Melissant
HC
,
Verdonck-de Leeuw
IM
,
Lissenberg-Witte
BI
,
Konings
IR
,
Cuijpers
P
,
Van Uden-Kraan
CF
.
“Oncokompas”, a web-based self-management application to support patient activation and optimal supportive care: a feasibility study among breast cancer survivors
.
Acta Oncol
.
2018
;
57
(
7
):
924
34
.
40.
Young
HN
,
Larson
TL
,
Cox
ED
,
Moreno
MA
,
Thorpe
JM
,
MacKinnon
NJ
.
The active patient role and asthma outcomes in an underserved rural community
.
J Rural Health
.
2014
;
30
(
2
):
121
7
. .
41.
Bos-Touwen
I
,
Schuurmans
M
,
Monninkhof
EM
,
Korpershoek
Y
,
Spruit-Bentvelzen
L
,
Ertugrul-van der Graaf
I
,
Patient and disease characteristics associated with activation for self-management in patients with diabetes, chronic obstructive pulmonary disease, chronic heart failure and chronic renal disease: a cross-sectional survey study
.
PloS One
.
2015
;
10
(
5
):
e0126400
. .
42.
Korpershoek
Y
,
Bos-Touwen
ID
,
De Man-Van Ginkel
JM
,
Lammers
JW
,
Schuurmans
MJ
,
Trappenburg
J
.
Determinants of activation for self-management in patients with COPD
.
Int J Chron Obstruct Pulmon Dis
.
2016
;
11
:
1757
. .
43.
McCabe
PJ
,
Stuart-Mullen
LG
,
McLeod
CJ
,
O Byrne
T
,
Schmidt
MM
,
Branda
ME
,
Patient activation for self-management is associated with health status in patients with atrial fibrillation
.
Patient Prefer Adherence
.
2018
;
12
:
1907
16
. .
44.
Mosen
DM
,
Schmittdiel
J
,
Hibbard
J
,
Sobel
D
,
Remmers
C
,
Bellows
J
.
Is patient activation associated with outcomes of care for adults with chronic conditions?
J Ambul Care Manage
.
2007
;
30
(
1
):
21
9
. .
45.
Zwerink
M
,
Brusse-Keizer
M
,
van der Valk
PD
,
Zielhuis
GA
,
Monninkhof
EM
,
van der Palen
J
,
Self management for patients with chronic obstructive pulmonary disease
.
Cochrane Database Syst Rev
.
2014
;
3
:
CD002990
. .
46.
Smith
R
,
Osadnik
C
,
Lee
AL
.
Educational topics and their rationale for inclusion within pulmonary rehabilitation–a systematic review
.
Patient Educ Couns
.
2020
.
47.
Dixon
A
,
Hibbard
J
,
Tusler
M
.
How do people with different levels of activation self-manage their chronic conditions?
Patient
.
2009
;
2
(
4
):
257
68
. .
48.
Blakemore
A
,
Hann
M
,
Howells
K
,
Panagioti
M
,
Sidaway
M
,
Reeves
D
,
Patient activation in older people with long-term conditions and multimorbidity: correlates and change in a cohort study in the United Kingdom
.
BMC Health Serv Res
.
2016
;
16
(
1
):
582
. .
49.
Benzo
R
,
Vickers
K
,
Ernst
D
,
Tucker
S
,
McEvoy
C
,
Lorig
K
.
Development and feasibility of a self-management intervention for chronic obstructive pulmonary disease delivered with motivational interviewing strategies
.
J Cardiopulm Rehabil Prev
.
2013
;
33
(
2
):
113
23
. .
50.
Linden
A
,
Butterworth
SW
,
Prochaska
JO
.
Motivational interviewing-based health coaching as a chronic care intervention
.
J Eval Clin Pract
.
2010
;
16
(
1
):
166
74
. .
51.
Stoilkova-Hartmann
A
,
Janssen
DJ
,
Franssen
FM
,
Spruit
MA
,
Wouters
EF
.
Attitudes of healthcare professionals providing pulmonary rehabilitation toward partnership in care
.
Heart Lung
.
2015
;
44
(
4
):
347
52
. .
52.
Greene
J
,
Hibbard
JH
,
Alvarez
C
,
Overton
V
.
Supporting patient behavior change: approaches used by primary care clinicians whose patients have an increase in activation levels
.
Ann Fam Med
.
2016
;
14
(
2
):
148
54
. .
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.